CultreCoat Low BME Cell Invasion Assay, 96 well

Cell migration / Invasion cell type - SCC6

Experiment
Cell migration / Invasion cell type - SCC6
Product
CultreCoat Low BME Cell Invasion Assay, 96 well from R&D Systems
Manufacturer
R&D Systems

Protocol tips

Protocol tips
Incubate at 37 oC in a CO2 incubator for 24 hours.

On the third day add 100 µl of Cell Dissociation Solution/ Calcein AM to bottom
chamber and incubate at 37 oC in a CO2 incubator for one hour
Downstream tips
Read plate at 485 nm excitation, 520 nm emission

Publication protocol

CultreCoat® Low BME Cell Invasion Assay was purchased from R&D Systems. Cells were plated in 96 well CultreCoat® plates with either vehicle or R428. 24 hours post therapy cell invasion was measured as per manufactures instructions.

Full paper   Login or join for free to view the full paper.

Reviews

CultreCoat Low BME Cell Invasion Assay, 96 well from R&D Systems has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Cell migration / Invasion cell type - SCC6 using CultreCoat Low BME Cell Invasion Assay, 96 well from R&D Systems.

Paper title
AXL is a logical molecular target in head and neck squamous cell carcinoma
Full paper
Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from R&D Systems for CultreCoat Low BME Cell Invasion Assay, 96 well below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing Cell migration / Invasion cell type - SCC6 using CultreCoat Low BME Cell Invasion Assay, 96 well from R&D Systems. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Become shareholder Discussions About us Contact Privacy Terms